CureAge
1 known investors
CureAge develops genetic therapies to treat peripheral nerve diseases, specifically targeting Neurofibromatosis type 1. The company aims to translate genetic medicine into cures for patients with rare nerve disorders.
Founders & leadership
Board
Investors · 1
Frequently asked questions
- What does CureAge do?
- CureAge develops genetic therapies to treat peripheral nerve diseases, specifically targeting Neurofibromatosis type 1. The company aims to translate genetic medicine into cures for patients with rare nerve disorders.
- Who are CureAge's investors?
- CureAge's investors include Deep Science Ventures.